Vaishali Sanchorawala Selected Research

Immunoglobulin Light Chains (Immunoglobulin Light Chain)

1/2022	Update on the Contemporary Treatment of Light Chain Amyloidosis Including Stem Cell Transplantation.
1/2021	Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis.
10/2020	Comparison of Ultrasound Features of Major Salivary Glands in Sarcoidosis, Amyloidosis, and Sjögren's Syndrome.
12/2019	A new era of amyloidosis: the trends at a major US referral centre.
1/2019	Long term outcome of patients treated on clinical trials of immunomodulatory agents for the treatment of Immunoglobulin light chain (AL) amyloidosis: A pooled analysis.
1/2019	Induction Therapy with Bortezomib and Dexamethasone and Conditioning with High-Dose Melphalan and Bortezomib Followed by Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis: Long-Term Follow-Up Analysis.
1/2019	Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body 18F-Florbetapir PET/CT.
1/2019	Treatment Options For Relapsed/refractory Systemic Light-Chain (AL) Amyloidosis: Current Perspectives.
10/2018	Systemic immunoglobulin light chain amyloidosis.
1/2018	High-Dose Melphalan and Stem Cell Transplantation in Patients on Dialysis Due to Immunoglobulin Light-Chain Amyloidosis and Monoclonal Immunoglobulin Deposition Disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vaishali Sanchorawala Research Topics

Disease

104	Immunoglobulin Light-chain Amyloidosis 12/2022 - 06/2002
39	Amyloidosis 09/2022 - 06/2002
11	Multiple Myeloma 04/2022 - 03/2003
8	Cardiomyopathies (Cardiomyopathy) 05/2022 - 06/2002
8	Paraproteinemias (Monoclonal Gammopathy) 11/2019 - 03/2003
7	Amyloid Plaque 12/2022 - 07/2011
4	Heart Failure 01/2021 - 10/2010
3	Proteinuria 10/2020 - 05/2003
3	Disease Progression 01/2020 - 01/2004
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2019 - 03/2003
2	Hyperpigmentation 04/2022 - 01/2021
2	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 05/2003
2	Myocardial Infarction 12/2020 - 09/2011
2	Renal Insufficiency (Renal Failure) 04/2020 - 06/2008
2	Fatigue 01/2020 - 01/2016
2	Infections 01/2020 - 12/2019
2	Proteostasis Deficiencies 10/2018 - 09/2018
2	Transthyretin-Related Hereditary Amyloidosis 09/2018 - 01/2013
2	Monoclonal Gammopathy of Undetermined Significance 03/2018 - 06/2008
2	Neoplasms (Cancer) 08/2013 - 06/2011
2	Hemorrhage 09/2012 - 05/2007
2	Dyspnea (Shortness of Breath) 07/2011 - 09/2005
1	Small Fiber Neuropathy 09/2022
1	Sjogren's Syndrome (Sjogren Syndrome) 05/2022
1	Diarrhea 01/2021
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Polyneuropathies (Polyneuropathy) 01/2021
1	Joint Diseases (Joint Disease) 12/2020
1	Macroglossia 12/2020
1	Carpal Tunnel Syndrome 12/2020
1	Ecchymosis 12/2020
1	Atrial Fibrillation 12/2020
1	Sarcoidosis (Schaumann Disease) 10/2020
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 03/2020
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2020
1	Vomiting 01/2020
1	Nausea 01/2020
1	COVID-19 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 10/2019
1	Cardiac Arrhythmias (Arrythmia) 01/2019
1	Herpes Zoster 04/2018
1	Opportunistic Infections (Opportunistic Infection) 04/2018

Drug/Important Bio-Agent (IBA)

47	Melphalan (Alkeran)FDA LinkGeneric 09/2022 - 06/2002
29	Amyloid (Amyloid Fibrils)IBA 09/2022 - 06/2002
25	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2022 - 03/2003
13	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 01/2007
12	Bortezomib (Velcade)FDA Link 01/2022 - 08/2009
11	Lenalidomide (CC 5013)FDA Link 04/2022 - 01/2007
10	Proteins (Proteins, Gene)FDA Link 05/2022 - 03/2011
8	Prealbumin (Transthyretin)IBA 09/2022 - 06/2011
6	daratumumabIBA 12/2022 - 01/2020
6	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2020 - 12/2010
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 12/2011
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 01/2020
4	Immunomodulating AgentsIBA 01/2021 - 01/2018
4	Immunoglobulins (Immunoglobulin)IBA 12/2020 - 06/2014
4	Proteasome InhibitorsIBA 12/2020 - 01/2017
3	Bendamustine Hydrochloride FDA Link 01/2020 - 02/2017
3	Pharmaceutical PreparationsIBA 02/2017 - 01/2016
2	CreatinineIBA 04/2022 - 05/2003
2	Thalidomide (Thalomid)FDA Link 01/2022 - 03/2003
2	ixazomibIBA 01/2022 - 01/2017
2	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 01/2019
2	venetoclaxIBA 11/2021 - 12/2020
2	SteroidsIBA 03/2020 - 08/2015
2	florbetapirIBA 01/2020 - 01/2020
2	pomalidomideIBA 11/2019 - 01/2016
2	Heparin (Liquaemin)FDA LinkGeneric 01/2018 - 09/2012
2	Immunoglobulin M (IgM)IBA 01/2015 - 12/2014
2	DiureticsIBA 12/2011 - 09/2003
1	Proline (L-Proline)FDA Link 05/2022
1	Diflunisal (Dolobid)FDA Link 01/2021
1	patisiranIBA 01/2021
1	selinexorIBA 01/2021
1	tafamidisIBA 01/2021
1	InotersenIBA 01/2021
1	FluorineIBA 01/2020
1	micaIBA 01/2020
1	Acetates (Acetic Acid Esters)FDA Link 01/2020
1	fibrin fragment D (D-dimer)IBA 10/2019
1	FibrinIBA 10/2019
1	N 30IBA 01/2019
1	Methylprednisolone FDA LinkGeneric 04/2018
1	Rituximab (Mabthera)FDA Link 04/2018

Therapy/Procedure

44	Stem Cell Transplantation 09/2022 - 03/2003
28	Therapeutics 12/2022 - 03/2003
13	Drug Therapy (Chemotherapy) 07/2022 - 06/2002
10	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2020 - 03/2003
4	Aftercare (After-Treatment) 12/2022 - 01/2004
3	Kidney Transplantation 04/2020 - 03/2003
3	Heart Transplantation (Grafting, Heart) 11/2019 - 10/2010
2	Organ Transplantation 05/2022 - 11/2019
1	Duration of Therapy 01/2022
1	Investigational Therapies (Experimental Therapy) 01/2021
1	Transplantation 01/2021
1	Immunomodulation 11/2019
1	Treatment Delay 01/2019
1	Defibrillators (Defibrillator) 01/2019
1	Immunotherapy 10/2018